News in brief: Key Neurotech phase III trial underway; London dates confirmed for Cannabis Europa; Vitura sets AGM date by Steve Jones September 22, 2026September 24, 2026 Drug development firm Neurotech International (NTI) has dosed the first patient in its pivotal phase III […]
Neurotech shares jump 25% as chairman speaks of ‘considerable opportunity’ by Steve Jones August 27, 2026August 27, 2026
News in brief: LGP elects directors; Neurotech appoints Davies as executive chairman by Adam Sheldon August 18, 2026August 18, 2026
Company news: Vantage Hemp; Neurotech International; MediPharm Labs/Beacon Medical; Cann Group by Martin Lane September 28, 2023April 30, 2024
Company news: Bod; Neurotech International; Emyria; Creso Pharma by Martin Lane August 23, 2022April 29, 2024
